25 results
8-K
EX-99.1
XCUR
Exicure Inc
16 May 24
Exicure, Inc. Reports Third Quarter 2023 Financial Results
4:50pm
to the wind down of R&D operations.
Net Loss: The Company had a net loss of $5.3 million for the quarter ended September 30, 2023, as compared to a net
8-K
XCUR
Exicure Inc
1 Dec 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:21pm
previously disclosed wind down of historical biotechnology activities and transition to an exploration of broader strategic alternatives, it was no longer … research and development expenses with its wind down activities in 2023. As a result, approximately $0.6 million of expenses were incorrectly
DEFA14A
rtpae
14 Nov 22
Additional proxy soliciting materials
4:20pm
8-K
EX-99.1
6xvas
14 Nov 22
Exicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:15pm
8-K
h865j1j7 1q2
27 Sep 22
Entry into a Material Definitive Agreement
7:13am
424B3
467c7xuy7psuqm
20 Jul 22
Prospectus supplement
4:51pm
8-K
5hoqm
5 Jan 22
Termination of a Material Definitive Agreement
5:08pm
424B5
m6unk5e73ow 0t
16 Dec 21
Prospectus supplement for primary offering
8:13am
8-K
j3mct bk5z
10 Dec 21
Exicure, Inc. Announces Results of Internal Investigation and Implementation of Strategic Measures to Reduce Cash Burn and Prioritize Pipeline Focus
5:25pm
8-K
EX-99.1
t77n4 pvdoku9r3s
10 Dec 21
Exicure, Inc. Announces Results of Internal Investigation and Implementation of Strategic Measures to Reduce Cash Burn and Prioritize Pipeline Focus
5:25pm